This inventor holds 17 USPTO granted patents and 21 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Protein Degradation. Top assignees: Dana-Farber-Cancer Institute Inc., Beth Israel Deaconess Medical Center, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newton, MA (US) (2022)
- Chestnut Hill, MA (US) (2022 - 2024)
Company Filing History:
17 out of 1,269 
1 out of 539 
Years Active: 2022-2026
Areas of Expertise:
Title: The Innovations of Eric S. Fischer: A Pioneer in Cancer Research
Introduction: Eric S. Fischer, based in Newton, MA, is a highly accomplished inventor with a portfolio of 10 patents to his name. His work primarily focuses on developing innovative solutions in the field of oncology. Specifically, he has made notable contributions through his research at the Dana-Farber Cancer Institute, which plays a significant role in advancing cancer treatment and understanding the complexities of cancer biology.
Latest Patents: Fischer's latest patents highlight his dedication to combating cancer through innovative compounds. One of his significant contributions is the development of degraders of WEE1 kinase. These bifunctional compounds target the Wee1 tyrosine kinase for degradation, presenting a novel approach to treatment. Additionally, he has developed immunomodulatory compounds that can be used in pharmaceutical compositions, offering methods to treat diseases characterized by aberrant protein activity through targeting cereblon.
Career Highlights: Throughout his career, Eric S. Fischer has focused on addressing cancer-related challenges through groundbreaking research. His patents reflect his commitment to enhancing therapeutic methods and improving patient outcomes. The integration of his innovative compounds into clinical applications holds the promise of advancing treatment methodologies in oncology.
Collaborations: Fischer is known for his collaborative efforts in the research community. He works alongside notable colleagues such as Nathanael Schiander Gray and Tinghu Zhang, which underscores the importance of teamwork in advancing scientific research. Their collective expertise contributes to the development of innovative solutions in the fight against cancer.
Conclusion: Eric S. Fischer's contributions to cancer research through his patents and collaborative efforts at the Dana-Farber Cancer Institute are commendable. His innovative approach to treatment and dedication to developing new therapeutic compounds illustrate the vital role inventors play in the advancement of medical science. As Fischer continues his work, the impact of his inventions will undoubtedly lead to significant improvements in cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile